SCHEMBL4238491

SCHEMBL4238491

O=C(Cl)/C=C(/Cl)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.46
CES1 P23141 5/20 0.46
CES2 O00748 4/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 2/20 0.46
DAO P14920 1/20 0.46
NAPRT Q6XQN6 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
CA2 P00918 3/20 0.45
CA12 O43570 2/20 0.45
CA1 P00915 2/20 0.45
CA9 Q16790 2/20 0.45
MAPK1 P28482 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
TRPA1 O75762 1/20 0.43
GSK3B P49841 1/20 0.43
HIF1A Q16665 1/20 0.43
AKT1 P31749 1/20 0.43
CYP3A4 P08684 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4238493 1.00 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL4238499 1.00 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL3809749 0.86 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL1536421 0.86 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL1536420 0.86 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL28417302 0.84 NFE2L2 (0.61) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL7080066 0.82 CES2 (0.52) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL7080067 0.82 CES2 (0.52) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL4398750 0.81 NFE2L2 (0.46) NFE2L2CES1CES2ALDH1A1TSHR
SCHEMBL10451071 0.79 CES2 (0.52) CES1CES2ALDH1A1TSHRCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101516365-A Inhibitors of undecaprenyl pyrophosphate synthase NOVARTIS AG (CH) 2009-08-26 CN disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 NFE2L2 3993/4885CES1 439/4885CES2 2205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.